Digest Network Come funziona
Digest / Comunicato

Compatibilità
Salva()
Condividi
Recapiti
Vuoi vedere nel tuo digest i prossimi comunicati di questo professionista?

Comunicati correlati

19/03/2026
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Ferring Announces Update to NCCN Guidelines Expanding Category 2A Recommendation for Nadofaragene Firadenovec-vncg (ADSTILADRIN®) in Patients with BCG-Unresponsive NMIBC
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
0
16/10/2025
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
Eventi
Industria
Ferring Expands Growing Body of Real-World Evidence Reinforcing Use of ADSTILADRIN® (nadofaragene firadenovec-vncg) in Urology Practices
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
0
17/05/2026
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
New Real-World Case Series Examines Re-Induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Clinical Practice
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
0